erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.white house to ban federal funds for clinics that discuss abortion with patients.

"we were quite surprised to find there were no significant differences," says study author.